Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Pfizer

The CDC endorses Novavax, a more traditional COVID vaccine, for adults

Adults who haven't gotten any COVID-19 shots should consider the new option, the agency said Tuesday. The spike protein vaccine is more typical than the mRNA types being broadly used against COVID.

WEKU

Novavax COVID shot for adults gains CDC advisers’ backing

Novavax Inc.’s shares surged after its COVID-19 vaccine won backing from a panel of U.S. public health advisers, a crucial step in providing officials with another tool against the virus as cases start to rise again.

Tribune News Service

CDC endorses new Novavax Covid vaccine

Two-dose shot will becomes fourth one to gain full approval later this week

The Independent UK

From analysis to the latest developments in health,
read the most diverse news in one place.

CDC advisers endorse more traditional Novavax COVID shot

Government advisers say U.S. adults who haven’t gotten any COVID-19 shots yet should consider a new option from Novavax

The Independent UK

COVID-19 antiviral prescriptions hard to fill, Qld medical body says, as demand ramps up

Patients with prescriptions for antiviral drugs after catching COVID-19 are struggling to get them filled at pharmacies across Queensland, a medical association says, as increased illegibility increases demand on stocks.

ABC News

A dire moment in the pandemic ... was the chance he'd been waiting for

How Sotiris Missailidis, head of R&D in Brazil's vaccine agency, used the COVID crisis to push through a game-changing effort for middle-income countries to invent their own mRNA vaccine.

WEKU

Covid vaccine protection ‘short lived,’ booster doses essential, study confirms

‘Continual updating of our vaccinations and booster shots is critical,’ scientists say

The Independent UK

Read news from The Economist, FT, and more,
with one subscription

Australia has ordered millions more COVID vaccines than it needs. What are the options to deal with them?

Australia has used less than a quarter of the hundreds of millions of COVID-19 vaccine doses it bought. What will happen to the rest?

ABC News

When can we stop worrying about COVID-19? Not yet, experts say

ORLANDO, Fla. — Scientists have suggested that once vaccines and treatment for COVID-19 became widely available, a surge might not require more than the basic precautions practiced during flu season. With the development of vaccines, pre-exposure treatment such as Evushield and post-exposure treatment such as Paxlovid, it’s natural to ask…

Orlando Sentinel

Bhutan-China ties won’t harm India’s interests: Bhutan Foreign Minister

After over two years of COVID-19-induced lockdown, Bhutan will open its doors for tourists on September 23 with a new expensive policy for international tourists and Indians as well. Bhutan Foreign Minister Tandi Dorji says the lessons of COVID-19 include better ties with neighbours, including China.

The Hindu

This Is What Whales Are Betting On Pfizer

A whale with a lot of money to spend has taken a noticeably bearish stance on Pfizer. Looking at options history for Pfizer (NYSE:PFE) we detected 16 strange trades.

Benzinga

Vaccine uptake slow as cases among youngest children rise

ATLANTA — Sesame Street’s Elmo, who is 3½, recently got his COVID-19 vaccine.

Tribune News Service

First study of its kind reports on period changes post-Covid-19 vaccination

A survey of 39,000 people who currently or formerly menstruate found that 42 percent of respondents had irregular or breakthrough bleeding after a COVID vaccine.

Inverse

Novavax (NVAX) Down As EU Adds Side Effects To COVID Jab Label

Shares of Novavax (NASDAQ: NVAX) fell 26.2% on Jul 14, after the European Medicines Agency's (TSE: EMA) Pharmacovigilance Risk Assessment Committee ("PRAC") updated the product label of Nuvaxovid, the company's COVID-19 vaccine, to include some potential side effects like severe aller

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

WEKU

The omicron subvariant dominating U.S. COVID-19 cases is more vaccine-resistant

The BA.5 strain represented 65% of cases from July 3 to 9, according to data from the Centers of Disease Control and Prevention.

ABC News

COVID-19 vaccines targeting the Omicron variant are on the way — but it could be worth getting a fourth dose now

Omicron is now the dominant strain of COVID-19 around the world and boosters targeting this variant are getting closer to being released.

Benzinga

What Are Whales Doing With Pfizer

A whale with a lot of money to spend has taken a noticeably bullish stance on Pfizer. Looking at options history for Pfizer (NYSE:PFE) we detected 11 strange trades.

Reuters

Ombudswoman says missing EU Pfizer vaccine deal texts are "wake-up call"

The European Union's ombudswoman criticised the European Commission for failing to find and publish text messages between the executive's president, Ursula von der Leyen, and the head of Pfizer negotiating a massive COVID-19 vaccine deal.

Get all your
news in one place.

100's of premium titles.
One news app.

The Guardian - UK

Watchdog reprimands EU executive for failing to share Von der Leyen texts

European Commission ‘gave no good reason’ why its president’s messages with Pfizer were not released

Tribune News Service

Novavax’s COVID vaccine gets US nod as latest pandemic weapon

Novavax Inc.’s COVID-19 vaccine was cleared by U.S. regulators, giving Americans another tool against the virus as cases start to rise again.

WEKU

These Brazilian besties are inventing an mRNA vaccine as a gift to the world

Pfizer and Moderna have refused to divulge details of how to make their cutting-edge COVID shots. Here's what two scientists — and longtime best friends — are doing about it.

The Independent UK

US regulators OK new COVID-19 shot option from Novavax

The U.S. is getting another COVID-19 vaccine choice

ABC News

Should you book in your second COVID-19 booster? Here's how Israel's fourth dose changed the fight against Omicron

For Australians over 30, a fourth COVID-19 vaccine jab is now available. In Israel, the first country in the world to embrace the second booster, the benefits for some people were dramatic.

Chronicle Live

New Google study reveals you've probably been pronouncing 25 brands like Nike, Adidas and Hermès wrong

Over the years, many have taken to search engine Google to find out exactly how to pronounce big name brands correctly.

360info

Less talk, more action needed to reform IP for all

IP laws are supposed to work to aid pharmaceutical innovation in rich nations. Can a new system support treating illnesses rife in developing economies, too?

1 … 43 44 45 46

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Intellectual Property

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.